TMCI
TREACE MEDICAL CONCEPTS, INC.
NASDAQ · Healthcare · Medical - Devices · US
$4.50
+5.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.32x
- Price / sales
- 1.43x
- Price / cash flow
- -20.07x
Enterprise value
- Enterprise value
- $319.7M
- EV / sales
- 1.56x
- EV / EBITDA
- -7.07x
- EV / EBIT
- -5.95x
- Market cap
- $292.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026